Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Emerging Company Profile

Clover: trimerizing fusion proteins

Chengdu-based Clover is targeting cancer and infectious disease pathways that depend on trimer formation

Hongjiang Li, Staff Writer
April 11, 2020 2:36 AM UTC

Clover is developing trimerized fusion proteins to target cancer and infectious disease pathways that depend on trimer formation.

The company has exclusive, worldwide rights to its Trimer-Tag platform from GenHunter Corp., which was co-founded by Sichuan Clover Biopharmaceuticals Inc. co-founder, President and Chairman Peng Liang...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Sichuan Clover Biopharmaceuticals Inc.